Cannon Financial Strategists »

Turn Therapeutics shares owned by Cannon Financial Strategists

Quarter-by-quarter ownership of Turn Therapeutics (TTRX) shares owned by Cannon Financial Strategists from 13F filings

Historical chart of Cannon Financial Strategists investment in Turn Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Turn Therapeutics held by Cannon Financial Strategists consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Turn Therapeutics by Cannon Financial Strategists

Quarter filed Position value Share count Share price at filing
2026-06-30 $73k 10k 7.30

More positions owned by Cannon Financial Strategists

Dimensional Etf Trust Intl Core Equity (DFIC)
Spdr Series Trust ST STR SP600SM C (SLYV)
Spdr Series Trust ST STR P500GRW (SPYG)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Vanguard Bd Index Fds Intermed Term (BIV)
Vanguard Index Fds Growth Etf (VUG)
Spdr Series Trust St Str Tips Etf (SPIP)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Vanguard Index Fds Total Stk Mkt (VTI)
American Centy Etf Tr Intl Eqt Etf (AVDE)
Ishares Tr Jpmorgan Usd Emg (EMB)
Capital Grp Fixed Incm Etf T Core Bond Etf (CGCB)
Vanguard Admiral Fds Smlcp 600 Val (VIOV)
Ishares Tr Cre U S Reit Etf (USRT)
Ishares Tr Ultra Short Dur (ICSH)

View all positions for Cannon Financial Strategists

Top funds holding Turn Therapeutics

Steel Peak Wealth Management
Ieq Capital
DDFG
Vanguard Capital Management
Wellington Shields & Co
Millennium Management
BlackRock
Aaron Wealth Advisors
Tamar Securities
Royal Bank of Canada
Bridgewater Advisors
Citadel Advisors
Brown Brothers Harriman & Co.
HighTower Advisors
RVW Wealth

View all funds holding Turn Therapeutics